rxstat › Classes › All Other Therapeutic Products

All Other Therapeutic Products: shortage status in Canada

7 of the 18 all other therapeutic products rxstat tracks are currently in shortage in Canada, including 1 designated Tier 3 (most serious) by Health Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Widespread shortageMesna3 of 3 reported products affected · est. return Aug 31, 2026 Widespread shortagePolystyrene Sulfonate3 of 6 reported products affected · est. return Oct 9, 2026 Partial shortageDeferasirox1 of 21 reported products affected Partial shortageDexrazoxane1 of 3 reported products affected Partial shortageLeucovorin1 of 6 reported products affected · est. return Jul 24, 2026 Partial shortageMethylene Blue1 of 2 reported products affected Partial shortagePolystyrene Sulfonate1 of 2 reported products affected Shortage anticipatedHydroxocobalamin0 of 1 reported products affected DiscontinuedAlcohol Anhydrous0 of 1 reported products affected DiscontinuedCobicistat0 of 1 reported products affected No current shortageDeferoxamine No current shortageDigoxin Immune Fab DiscontinuedDimercaprol0 of 1 reported products affected DiscontinuedLanthanum0 of 4 reported products affected No current shortageNaloxone No current shortageProtamine No current shortageSevelamer No current shortageSevelamer Carbonate

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.